Regular Article
Time-Dependent Impairment of Inhibitory Avoidance Retention in Rats by Posttraining Infusion of a Mitogen-Activated Protein Kinase Kinase Inhibitor into Cortical and Limbic Structures,☆☆

https://doi.org/10.1006/nlme.1999.3913Get rights and content

Abstract

Mitogen-activated protein kinase (MAPK) is abundantly expressed in postmitotic neurons of the developed nervous system. MAPK is activated and required for induction of long-term potentiation (LTP) in the CA1 area of the hippocampus, which is blocked by the specific inhibitor of the MAPK kinase, PD 098059. Recently it was demonstrated that MAPK is activated in the hippocampus after training and is necessary for contextual fear conditioning learning. The present work tests the role of the MAPK cascade in step-down inhibitory avoidance (IA) retention. PD 098059 (50 μM) was bilaterally injected (0.5 μl/side) into the CA1 region of the dorsal hippocampus or entorhinal cortex at 0, 90, 180, or 360 min, or into the amygdala or parietal cortex at 0, 180, or 360 min after IA training in rats using a 0.4-mA foot shock. Retention testing was carried out 24 h after training. PD 098059 impaired retention when injected into the dorsal hippocampus at 180 min, but not 0, 90, and 360 min after training. When infused into the entorhinal cortex, PD 098059 was amnestic at 0 and 180 min, but not at 90 and 360 min after training. The MAPKK inhibitor also impairs IA retention when infused into the parietal cortex immediately after training, but not at 180 or 360 min. Infusions performed into amygdala were amnestic at 180 min, but not at 0 and 360 min after training. Our results suggest a time-dependent involvement of the MAPK cascade in the posttraining memory processing of IA; the time dependency is different in the hippocampus, amygdala, entorhinal cortex, or parietal cortex of rats.

References (27)

  • M.R. Vossler et al.

    cAMP activates MAP kinase ELK-1 through a B-Raf- and Rap-1 dependent pathway

    Cell

    (1997)
  • R.D. Alessi et al.

    PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

    Journal of Biological Chemistry

    (1995)
  • P. Ardenghi et al.

    Late and prolonged post-training memory modulation in entorhinal and parietal cortex by drugs acting on the cAMP/protein kinase A signalling pathway

    Behavioural Pharmacology

    (1997)
  • Cited by (92)

    • Transplantation of ERK gene-modified bone marrow mesenchymal stem cells ameliorates cognitive deficits in a 6-hydroxydopamine rat model of Parkinson's disease

      2023, Neuroscience Letters
      Citation Excerpt :

      It has been reported previously that ERK plays a protective role in nerve tissue injuries[28] by promoting neuron proliferation and differentiation, which is beneficial for the recovery and establishment of synapses. ERK is able to enhance synaptic plasticity[29] and participate in regulating LTP signaling pathways[30], which thus regulates learning and memory formation. In the present study, compared with BMSCs alone transplanted rats, ERK-BMSCs transplantation exhibited superior efficiency against cognition impairments, suggesting that ERK promoted the differentiation of BMSCs into neuron-like cells and thus improved the ability of BMSCs to recover and rebuild DA neuronal pathways[31].

    View all citing articles on Scopus

    This work was supported by PRONEX and Fundaçá VITAE, Brazil.

    ☆☆

    Address correspondence and reprint request to Roger Walz, Centro de Memória, Departamento de Bioquı́mica, Instituto de Ciências Básicas da Saúde, UFRGS, Ramiro Barcelos 2600 (Anexo), 90035-003 Porto Alegre, RS, Brazil. Fax: 55 516 5535. E-mail: [email protected].

    View full text